SCHEMBL3689392

SCHEMBL3689392

CON=C(C(=O)O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
GAA P10253 1/20 0.44
CYP2C19 P33261 1/20 0.44
CES1 P23141 5/20 0.42
CES2 O00748 4/20 0.42
TYMP P19971 1/20 0.42
LMNA P02545 2/20 0.41
F2 P00734 1/20 0.41
POLB P06746 2/20 0.41
ALDH1A1 P00352 2/20 0.41
DAO P14920 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
MAPT P10636 3/20 0.40
RAB9A P51151 3/20 0.40
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 2/20 0.40
NPC1 O15118 2/20 0.40
PKM P14618 1/20 0.40
SRC P12931 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3958996 1.00 TSHR (0.48) TSHRGAACYP2C19CES1CES2
SCHEMBL8007984 1.00 TSHR (0.48) TSHRGAACYP2C19CES1CES2
SCHEMBL2045476 0.87 TSHR (0.44) TSHRGAACYP2C19CES1CES2
SCHEMBL2045474 0.87 TSHR (0.44) TSHRGAACYP2C19CES1CES2
SCHEMBL9900446 0.86 CES2 (0.50) TSHRGAACYP2C19CES1CES2
SCHEMBL9900449 0.86 CES2 (0.50) TSHRGAACYP2C19CES1CES2
SCHEMBL3689389 0.86 TSHR (0.47) TSHRGAACYP2C19CES1CES2
SCHEMBL3689388 0.86 TSHR (0.47) TSHRGAACYP2C19CES1CES2
SCHEMBL7805644 0.86 CES1 (0.48) TSHRGAACYP2C19CES1CES2
SCHEMBL7651351 0.86 CES1 (0.48) TSHRGAACYP2C19CES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112851546-B Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof 江西天宇化工有限公司 2023-10-03 CN claimed
CN-1111536-C Preparation method of 13-ester derivatives of milbemycins and intermediates thereof SANKYO CO (JP) 2003-06-18 CN claimed
CN-1310719-A Process for producing 13-ester derivatives of milbemycins SANKYO CO (JP) 2001-08-29 CN claimed
CN-1046275-C 2-methoxyiminophenyl-N-methylacetamide derivatives, process for their preparation, their use and compositions containing them BASF AG (DE) 1999-11-10 CN claimed
EP-0869963-A1 ARTHROPODICIDAL AND FUNGICIDAL ORGANOSILANES AND ORGANOGERMANES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-10-14 EP claimed
WO-1996017851-A1 ARTHROPODICIDAL AND FUNGICIDAL ORGANOSILANES AND ORGANOGERMANES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-06-13 WO claimed
CN-1118165-A Ortho-substituted 2-methoxyiminophenylacetic acid methylamides BASF AG (DE) 1996-03-06 CN claimed
JP-7076564-A None JP disclosed
CN-117185954-A Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof 江西天宇化工有限公司 2023-12-08 CN disclosed
CN-112851546-B Preparation method of (E) -2-methyl-alpha-methoxyiminophenylacetic acid methyl ester and intermediate thereof 江西天宇化工有限公司 2023-10-03 CN disclosed
CN-112661732-B Furanol derivative and preparation method and application thereof 湖南化研院检测技术有限公司 2023-08-04 CN disclosed
US-11647750-B2 Active compound combinations having insecticidal/acaricidal properties BAYER AKTIENGESELLSCHAFT (DE) 2023-05-16 US disclosed
CN-111217828-B Preparation method of lepistamycin and intermediate thereof 浙江海正药业股份有限公司 2022-11-25 CN disclosed
CN-1098089-A The method for preparing 2-oximino acetogenin BAYER AG (DE) 1995-02-01 CN disclosed
EP-0600835-A1 Method for the production of derivatives of phenylacetic acid esters CIBA-GEIGY AG (CH) 1994-06-08 EP disclosed
US-4490524-A BACTERICIDES TOYO JOZO KABUSHIKI KAISHA (JP) 1984-12-25 US disclosed
US-4203896-A WITH MERCURIC ACETATE AND ACETIC ACID, ACIDIC HYDROLYSIS OF N-PROPENYL GROUP ELI LILLY AND COMPANY (US) 1980-05-20 US disclosed
US-4178443-A Derivatives of 7 [-substituted oxyimins acetamido] cephalosporins HOFFMANN-LA ROCHE INC. (US) 1979-12-11 US disclosed
US-4144232-A Substituted azetidin-2-one antibiotics ELI LILLY AND COMPANY (US) 1979-03-13 US disclosed
US-4138555-A BACTERICIDES GLAXO LABORATORIES, LIMITED (GB) 1979-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11647750-B2 Active compound combinations having insecticidal/acaricidal properties ACHE, CYP51A1, ACAT1 TSHR 4661/4885GAA 73/4885CYP2C19 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.